Peer-Support Cognitive Behavioral Intervention for Military Life Transitions (Mil-iTransition)

NCT07930234, Not applicable, Completed, Henry M. Jackson Foundation for the Advancement of Military Medicine

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Field	Value	Source
Title	Peer-Support Cognitive Behavioral Intervention for Military Life Transitions (Mil-iTransition)	ClinicalTrials.gov
NCT number	NCT07930234	ClinicalTrials.gov
Status	Completed	ClinicalTrials.gov
Phases	Not applicable	ClinicalTrials.gov
Enrollment	40 participants, actual	ClinicalTrials.gov
Lead sponsor	Henry M. Jackson Foundation for the Advancement of Military Medicine	ClinicalTrials.gov
Conditions	Peer-Support Intervention, Military-to-Civilian Transition, Medical Disability, Suicide Prevention, Pilot Randomized Controlled Trial	ClinicalTrials.gov
Interventions	Telephone- Based Peer Support + TAU	ClinicalTrials.gov
First posted	2026-11-12	ClinicalTrials.gov
Last updated	2026-11-12	ClinicalTrials.gov

Registered outcomes 17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description	Source
Primary	Mil-iTransition Feedback Interview	3-months post-baseline	The Mil-iTransition Feedback Interview, administered at the 3-month follow-up, assesses perceived benefit, comfort, and satisfaction with study participation, including the intervention. Its acceptability items, in its third section, are administered to participants in the Mil-iTransition arm only.	ClinicalTrials.gov
Primary	Feasibility	6-months post-baseline	Feasibility is assessed against four benchmarks: (1) at least 50% enrollment among eligible Service members; (2) at least 80% of participants in the Mil-iTransition arm engaging in at least one call with a Peer Facilitator; (3) a median of at least 4 total hours of calls with a Peer Facilitator; and (4) at least 80% of participants in both arms completing the 3- and 6-month follow-up assessments.	ClinicalTrials.gov
Primary	Mil-iTransition Fidelity Observation Form	During the 12-week intervention period	Fidelity is rated on the Mil-iTransition Fidelity Observation Form and competency on a modified Cognitive Therapy Rating Scale. Peer Facilitators rate themselves after each of the 12 appointments, and a study team member rates 20% of the audio-recorded appointments.	ClinicalTrials.gov
Secondary	Beck Depression Inventory-II	Baseline; 3- and 6-months post-baseline	Beck Depression Inventory-II (BDI-II; Beck et al., 1996) is a 21-item self-report instrument used to detect and estimate overall depression severity.	ClinicalTrials.gov
Secondary	Beck Hopelessness Scale	Baseline; 3- and 6-months post-baseline	Beck Hopelessness Scale (BHS; Beck \& Steer, 1988) is a 20-item self-report instrument consisting of true-false statements that assesses the extent of positive and negative beliefs about the future.	ClinicalTrials.gov
Secondary	Coping Self-Efficacy	Baseline; 3- and 6-months post-baseline	Coping Self-Efficacy (CSE; Chesney et al., 2006) is a 13-item measure assessing coping self-efficacy across three subscales - (1) problem-focused coping, (2) stopping unpleasant emotions and thoughts, and (3) enlisting support.	ClinicalTrials.gov
Secondary	Enriched Life Scale	Baseline; 3- and 6-months post-baseline	Enriched Life Scale (ELS; Angel et al., 2018) is a 40-item self-report measure that assesses physical and mental health, sense of purpose, engaged citizenship, and genuine relationships. Responses are measured on 5-point Likert scales.	ClinicalTrials.gov
Secondary	General Health Questionnaire	Baseline; 3- and 6-months post-baseline	General Health Questionnaire-12 (GHQ-12; Goldberg \& Williams, 1988) is a 12-item measure to screen for non-psychotic and minor psychiatric disorders in research settings, such as anxiety and depression. Responses on the GHQ-12 are not diagnostic of any disorder or condition.	ClinicalTrials.gov
Secondary	Interpersonal Needs Questionnaire	Baseline; 3- and 6-months post-baseline	Interpersonal Needs Questionnaire (INQ; Van Orden et al., 2012) is a 15-item self-report measure that identifies the etiology of suicidal desire/behavior, and specifically, assesses perceived burdensomeness and thwarted belongingness.	ClinicalTrials.gov
Secondary	Transitioning to Civilian Life Scale	Baseline; 3- and 6-months post-baseline	Transitioning to Civilian Life Scale (TCLS; Weiss, Rubin, \& Graeser, 2019) is a 15-item self-report measure to assess how well military Service members are transitioning to civilian life (e.g., stable finances, hobbies). Responses are on a 5-point Likert scale ranging strongly agree to strongly disagree.	ClinicalTrials.gov
Secondary	Columbia Suicide-Severity Rating Scale	Baseline; 3- and 6-months post-baseline	Columbia Suicide-Severity Rating Scale (C-SSRS; Posner et al., 2011) is a clinician-administered measure that assesses for suicide ideation and attempt behavior based on established definitions. The C-SSRS was designed to uniquely address the need for a summary measure to track change in the severity/density of suicidality. There are two versions of the C-SSRS. At baseline, the "Lifetime/Recent" version of the C-SSRS will be administered over the telephone by a Blind Assessor. At 3- and 6-month follow-ups, the "Since Last Visit" version of the C-SSRS will be administered over the telephone by a Blind Assessor.	ClinicalTrials.gov
Secondary	Suicide Cognitions Scale	Baseline; 3- and 6-months post-baseline	Suicide Cognitions Scale - Short (SCS-S; Bryan et al., 2017) is a 9-item self-report version of the SCS scale designed to assess cognitions and beliefs that are commonly expressed by suicidal individuals.	ClinicalTrials.gov
Secondary	Suicide-Related Coping Measure	Baseline; 3- and 6-months post-baseline	Suicide-Related Coping Measure (SRCM; Stanley et al., 2017) is a 17-item self-report instrument used to assess knowledge of and confidence in using internal coping strategies and external resources to manage suicidal thoughts and urges.	ClinicalTrials.gov
Secondary	Modified Actual Help-Seeking Questionnaire	Baseline; 3- and 6-months post-baseline	Modified Actual Help-Seeking Questionnaire (AHSQ; Rickwood \& Braithwaite, 1994) is a self-report measure that assesses recent help-seeking behavior from various sources (e.g., intimate partner, friend, behavioral health professional, chaplain) as well as beliefs about whether or not the subsequent response was helpful or harmful.	ClinicalTrials.gov
Secondary	General Help-Seeking Questionnaire	Baseline; 3- and 6-months post-baseline	General Help-Seeking Questionnaire (GHSQ; Rickwood et al., 2005) is a self-report measure assessing the likelihood that the individual would seek help from various sources (i.e., those included in the AHSQ). Responses are on a 7-point Likert scale ranging from extremely unlikely to extremely likely.	ClinicalTrials.gov
Secondary	Perceived Barriers to Care	Baseline; 3- and 6-months post-baseline	Perceived Barriers to Care (PBC; Hoge et al., 2004) is a 13-item self-report scale used to assess perceived barriers to psychiatric treatment, particularly stigmatization. Four military-specific items were administered to all participants.	ClinicalTrials.gov
Other	The MSRC Common Data Elements	Baseline; 3- and 6-months post-baseline	The MSRC Common Data Elements V2.3 are a battery required by the research sponsor. Items assessing psychological health (items 21-71: anxiety sensitivity, posttraumatic stress disorder symptoms, traumatic brain injury, insomnia, and alcohol use) are administered online, and items assessing suicide-related thoughts and behaviors (items 1-20 and items 72-91) are administered over the telephone by a Blind Assessor, at baseline and at the 3- and 6-month follow-ups.	ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as	Source

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Category	Value	Spread	Units	Source

Participant flow 0

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants	Units counted	Source

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

Type	Event	Organ system	Group	Affected	At risk	Events	Source

Adverse event totals 0

The totals the trial posted for each group.

Total	Group	Affected	At risk	Source

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison	Source

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

Test	Named as	Source

Source 4

Field	Value	Source
Release	trials-2026-11-12-0.3.0	ClinicalTrials.gov
Release manifest SHA-256	4a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391	ClinicalTrials.gov
Registry capture	2026-11-12	ClinicalTrials.gov
Results copy, AACT	2026-03-23	ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.3.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.